Differential modulation of human basophil functions through PGD2 receptors DP and CRTH2/DP2 - 25/08/11
Abstract |
Rationale |
Both PGD receptor (DP) and CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells)/DP2 are high-affinity receptors for PGD2. Previous studies have demonstrated that PGD2 enhances releasability and induces CRTH2/DP2-mediated migration in human basophils. We comprehensively explored the precise effects of PGD2 as well as receptor usage on human basophils.
Methods |
DP and CRTH2/DP2 transcripts were quantified by real-time PCR. We studied the effects of selective agonists (DP: BW245C; CRTH2/DP2: DK-PGD2) and/or antagonists (DP: BWA868C; CRTH2/DP2: ramatroban) on Ca2+ mobilization, migration, degranulation, CD11b expression and survival of human basophils.
Results |
Basophils expressed 100-fold higher levels of CRTH2/DP2 transcripts compared with DP transcripts. Ca2+ influx was induced by either PGD2 or DK-PGD2 but not by BW245C. Basophils treated with PGD2 were completely desensitized to subsequent stimulation with DK-PGD2, but not vice versa. DK-PGD2 as well as PGD2 induced migration and enhanced degranulation, and those effects were completely antagonized by ramatroban. In contrast, BW245C exhibited inhibitory effects on basophil migration. CD11b expression was also up-regulated by PGD2 or DK-PGD2 but not by BW245C. Although PGD2 significantly shortened the basophil life-span, neither DK-PGD2 nor BW245C did.
Conclusions |
CRTH2/DP2 activation is necessary and sufficient for the pro-inflammatory effects of PGD2 (migration, degranulation and CD11b expression), while DP activation may mediate anti-inflammatory effects by negatively regulating basophil functions. The effects of PGD2 on longevity imply a mechanism(s) other than via DP or CRTH2/DP2. CRTH2/DP2 on basophils may afford opportunities for therapeutic targeting in allergic inflammation.
Le texte complet de cet article est disponible en PDF.![]() | Funding: Ministry of Education, Science, Sports and Culture of Japan |
Vol 113 - N° 2S
P. S101 - février 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?